| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000052098 |
| P698 | PubMed publication ID | 11244268 |
| P2093 | author name string | C L Bassetti | |
| M Gugger | |||
| J Mathis | |||
| C W Hess | |||
| D Mauerhofer | |||
| P433 | issue | 2 | |
| P921 | main subject | restless legs syndrome | Q916280 |
| P304 | page(s) | 67-74 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | European Neurology | Q1376833 |
| P1476 | title | Restless legs syndrome: a clinical study of 55 patients | |
| P478 | volume | 45 |
| Q36868330 | A further evaluation of the cognitive deficits associated with restless legs syndrome (RLS). |
| Q36607081 | A new look at an under-diagnosed poorly treated condition: restless legs syndrome. |
| Q26776231 | A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis |
| Q91896231 | Abnormal Circadian Modification of Aδ-Fiber Pathway Excitability in Idiopathic Restless Legs Syndrome |
| Q22251450 | Advances in pediatric restless legs syndrome: Iron, genetics, diagnosis and treatment |
| Q33911121 | Anxiety levels among Turkish public transportation drivers: a relation to restless legs syndrome? |
| Q37644659 | Demographic and clinical characteristics of patients with restless legs syndrome in spine clinic |
| Q34026340 | Diagnosis and management of restless legs syndrome in children |
| Q43734106 | Effects of restless legs syndrome on quality of life and psychological status in patients with type 2 diabetes |
| Q37116481 | Evaluating daytime alertness in individuals with Restless Legs Syndrome (RLS) compared to sleep restricted controls |
| Q34125935 | Gabapentin enacarbil (XP13512/GSK1838262) as an alternative treatment to dopaminergic agents for restless legs syndrome |
| Q61980338 | Genetics of Restless Legs Syndrome (RLS) |
| Q48178998 | Growing pains: twin family study evidence for genetic susceptibility and a genetic relationship with restless legs syndrome |
| Q30656967 | Imaging brain functional and metabolic changes in restless legs syndrome |
| Q26766416 | Intractable restless legs syndrome: role of prolonged-release oxycodone-naloxone |
| Q38202686 | Investigational approaches to therapies for restless legs syndrome |
| Q22251258 | Le syndrome des jambes sans repos |
| Q48479809 | Nature and variants of idiopathic restless legs syndrome: observations from 152 patients referred to secondary care in the UK. |
| Q33875622 | Nerve Decompression and Restless Legs Syndrome: A Retrospective Analysis |
| Q38867027 | Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects. |
| Q64911639 | Overview: A Framework for the Discussion of Sleep in Multiple Sclerosis. |
| Q43467467 | Pediatric restless legs syndrome: analysis of symptom descriptions and drawings |
| Q44638503 | Pergolide-associated ‘sleep attacks’ in a patient with restless legs syndrome |
| Q46923625 | Restless legs symptoms without periodic limb movements in sleep and without response to dopaminergic agents: a restless legs-like syndrome? |
| Q48332889 | Restless legs syndrome and periodic leg movements in sleep |
| Q35789174 | Restless legs syndrome and periodic limb movement disorder in the elderly |
| Q38217286 | Restless legs syndrome/Willis Ekbom disease: evaluation and treatment |
| Q34136122 | Restless legs syndrome: Understanding its consequences and the need for better treatment |
| Q34566322 | Restless legs syndrome: a sensorimotor disorder of sleep/wake motor regulation |
| Q34273561 | Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health |
| Q37165507 | Restless legs syndrome: pathophysiology, diagnosis and treatment |
| Q37971861 | Sleep-related movement disorders |
| Q37403311 | The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions ("mimics"). |
| Q53159076 | The high frequency of restless legs syndrome in patients with amyotrophic lateral sclerosis. |
| Q36774971 | The prevalence of restless legs syndrome across the full spectrum of kidney disease |
| Q34409491 | The use of rotigotine in the treatment of restless legs syndrome |
| Q36575981 | Time to REST: epidemiology and burden |
| Q47743879 | While Isolated Periodic Limb Movement Disorder Significantly Impacts Sleep Depth and Efficiency, Co-Morbid Restless Leg Syndrome Mainly Exacerbates Perceived Sleep Quality. |
| Q79764878 | [Restless legs syndrome in childhood] |
Search more.